All posts by: Michael Zand

About Michael Zand

Study prompts new ideas on cancers’ origins – Medical Xpress

Continue reading

2017-12-16 NEWS

Medical Xpress

Study prompts new ideas on cancers’ origins
Medical Xpress
Graduate student Megan Radyk and Jason Mills, M.D., Ph.D., led a study revealing that although many cancer therapies target rapidly dividing stem cells, mature cells also seem to play a key role in initiating cancer, at least in forming precancerous

and more »

Continue reading

2017-12-16 NEWS

Digital Journal

Gene therapy and possible cure for hemophilia A
Digital Journal
This is the therapeutic delivery of nucleic acid into a patient’s cells as a drug to treat disease. Gene therapy is a way to fix a genetic problem at its source, involving replacing a mutated gene that causes disease with a healthy copy of the gene; or
Trial gene therapy was a big success for Billericay dad Jake OmerEcho
Haemophilia A trial results ‘mind-blowing’Daily Times
‘Mind-blowing’ trial could transform treatment for haemophilia sufferersBT Sport
Brinkwire (press release)
all 7 news articles »
Continue reading

2017-12-16 NEWS

BioWorld Online

Tigenix gets EMA nod for off-the-shelf stem cell therapy in Crohn’s disease
BioWorld Online
LONDON – Eight years on from securing the first EMA approval for an autologous cell therapy, Tigenix NV has done it again, getting the nod for the first allogeneic adipose-derived stem cell therapy, Alofisel (Cx601, darvadstrocel), in the treatment of

and more »

Continue reading

2017-12-15 NEWS

Bluebird Bio, TC BioPharm Partner to Develop Gamma Delta CAR T-cell Therapy Candidates
Immuno-Oncology News
Bluebird bio and TC BioPharm recently announced a new partnership to develop gamma delta CAR T-cell product candidates for the treatment of cancer. The collaboration and licensing agreement were established to advance TC BioPharm’s CAR-engineered gamma